Regulation of growth and proliferation in B cell subpopulations

Immunological Reviews
|January 1, 1982
PubMed

The activation of B lymphocyte subpopulations by anti-immunoglobulin and by LPS has been examined. All resting B cells were stimulated to grow larger (i.e. to go from G0 phase to mid G1 phase of the cell cycle) by the continuous presence of anti-mu antibodies. A subpopulation oif these B cells, 30-50% in normal mouse strains, entered S phase in response to large doses of anti-mu. This subpopulation, probably Lyb5+, was completely absent in mice with the xid-determined immune defect. Another, apparently distinct subpopulation, comprising about 25% of the cells, and probably present in xid mice, was sensitive to a proliferative signal delivered by LPS, if the cells had first been cultured for 24 h in the presence of a dose of anti-mu that was sufficient to cause cell enlargement. The fraction of B cells responding to LPS in this way was significantly larger than the fraction responding to LPS alone, suggesting that anti-mu is superior to LPS at inducing the G0 to G1 transition. Based on these results we propose a model of the control of B cell growth and proliferation. Anti-Ig antibodies, or epitopes on conventional antigens, combine with and cross-link B cell receptors, causing the cells to enter G1 and to develop sensitivity to late G1 stimuli, which determine whether they will then enter S phase. These stimuli are provided either by a high dose of anti-mu or by LPS. These agents may work directly or may stimulate other cells to produce B cell Growth Factor (BCGF) and/or related regulatory molecules which may be the actual late G1 stimuli. Distinct B cell types are sensitive to distinct mechanisms for control of proliferation. A new monoclonal antibody, 14G8, which recognizes only a fraction of B cells (30% in normal mice and about 65% in xid mice), was used to separate B cell subpopulations based on the presence or absence of the cell surface antigen recognized by this antibody. The results suggest that 14G8 expression is negatively correlated with Lyb5 expression, although not absolutely. Indeed 14G8+ B cells respond quite well to anti-mu (32% the cells enter S phase). Since Lyb5- B cells are believed not to proliferate in response to anti-mu, this would suggest that a sizeable fraction of the 14G8+ B cells are also Lyb5+. The 14G8+ and 14G8- B cell subpopulations were found to be functionally distinct in that the former responded very well to LPS, whereas the latter responded very poorly. Models of B cell development based on expression of these membrane antigens are presented.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...